Patients with PD-L1 expression on immune cells had significantly longer PFS than those without (11.3 months vs. 7.0 months, p = 0.02) and notably, this correlation with survival was not demonstrated with PD-L1 expression on tumor cells [58]. Here, CD274 is linked to neoplasm.